SCHWAB GISELA MD Insider Trading
Get the latest insider transactions of SCHWAB GISELA MD. SCHWAB GISELA MD is Chief Medical Officer in ABGENIX INC ($ABGX) and EVP and Chief Medical Officer in EXELIXIS, INC. ($EXEL) and Pres Prod Dev & Med Aff & CMO in EXELIXIS, INC. ($EXEL) and Pres, Prod Dev & Med Aff & CMO in EXELIXIS, INC. ($EXEL) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA). Discover the current value of SCHWAB GISELA MD shares.
Address: 6701 KAISER DRIVE FREMONT 94555CA
SCHWAB GISELA MD is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| ABGX | ABGENIX INC | Chief Medical Officer | 0 | 0.00 |
| EXEL | EXELIXIS, INC. | Pres, Prod Dev & Med Aff & CMO, Pres Prod Dev & Med Aff & CMO, EVP and Chief Medical Officer | 714,078 | 14,688,584.46 |
| GNCA | GENOCEA BIOSCIENCES, INC. | Director | 0 | 0.00 |
Insider Trading Transactions of SCHWAB GISELA MD
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.90 | 100,000 | 190,000 | 714,078 |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 25.38 | 100,000 | 2,538,000 | 614,078 |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.90 | 100,000 | 190,000 | 150,000 |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 50,000 | 85,000 | 663,482 |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 25.00 | 50,000 | 1,250,000 | 613,482 |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 50,000 | 85,000 | 0 |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 50,000 | 85,000 | 663,482 |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 23.00 | 50,000 | 1,150,000 | 613,482 |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 50,000 | 85,000 | 50,000 |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 72,885 | 0 | 613,482 |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 50,000 | 85,000 | 590,597 |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 22.50 | 50,000 | 1,125,000 | 540,597 |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 50,000 | 85,000 | 590,597 |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 22.35 | 50,000 | 1,117,500 | 540,597 |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 50,000 | 85,000 | 150,000 |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 50,000 | 85,000 | 100,000 |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 21.91 | 2,858 | 62,619 | 540,597 |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 9,745 | 0 | 487,144 |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 71,293 | 0 | 558,437 |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 22.56 | 14,982 | 337,994 | 543,455 |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 9,745 | 0 | 487,144 |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 71,293 | 0 | 558,437 |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 22.56 | 14,982 | 337,994 | 543,455 |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 20.16 | 2,685 | 54,130 | 489,667 |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 20.16 | 9,685 | 195,250 | 479,982 |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 20.16 | 2,583 | 52,073 | 477,399 |
| Sep 04 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 9,745 | 0 | 335,708 |
| Sep 04 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 21.58 | 2,517 | 54,317 | 333,191 |
| Jun 05 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 100,000 | 170,000 | 425,963 |
| Jun 05 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 22.96 | 100,000 | 2,296,000 | 325,963 |
| Jun 05 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 100,000 | 170,000 | 200,000 |
| Apr 24 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 100,000 | 170,000 | 425,122 |
| Apr 24 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 26.00 | 100,000 | 2,600,000 | 325,122 |
| Apr 24 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 100,000 | 170,000 | 300,000 |
| Apr 24 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 100,000 | 170,000 | 425,122 |
| Apr 24 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 26.00 | 100,000 | 2,600,000 | 325,122 |
| Apr 24 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 100,000 | 170,000 | 300,000 |
| Mar 06 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 1.70 | 100,000 | 170,000 | 425,122 |
| Mar 06 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 19.20 | 50,000 | 960,000 | 375,122 |
| Mar 06 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 19.60 | 50,000 | 980,000 | 325,122 |
| Mar 06 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 1.70 | 100,000 | 170,000 | 400,000 |
| Feb 21 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.51 | 40,000 | 220,400 | 365,122 |
| Feb 21 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 21.50 | 40,000 | 860,000 | 325,122 |
| Feb 21 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.51 | 40,000 | 220,400 | 0 |
| Feb 18 2020 | GNCA | GENOCEA BIOSCIENCES, INC. | Schwab Gisela | Director | Option Exercise | 2.10 | 9,375 | 19,688 | 9,375 |
| Feb 18 2020 | GNCA | GENOCEA BIOSCIENCES, INC. | Schwab Gisela | Director | Option Exercise | 2.10 | 9,375 | 19,688 | 9,375 |
| Feb 07 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.51 | 50,000 | 275,500 | 375,122 |
| Feb 07 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 18.37 | 50,000 | 918,500 | 325,122 |
| Feb 07 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.51 | 50,000 | 275,500 | 40,000 |
| Jan 09 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.51 | 50,000 | 275,500 | 375,122 |
| Jan 09 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 17.96 | 50,000 | 898,000 | 325,122 |
| Jan 09 2020 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.51 | 50,000 | 275,500 | 90,000 |
| Dec 06 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 15,592 | 0 | 329,149 |
| Dec 06 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 17.67 | 4,027 | 71,157 | 325,122 |
| Dec 05 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.51 | 50,000 | 275,500 | 363,557 |
| Dec 05 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 16.22 | 50,000 | 811,000 | 313,557 |
| Dec 05 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.51 | 50,000 | 275,500 | 140,000 |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 16.51 | 9,685 | 159,899 | 316,140 |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 16.51 | 9,685 | 159,899 | 316,140 |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 16.51 | 2,583 | 42,645 | 313,557 |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 16.51 | 2,583 | 42,645 | 313,557 |
| Nov 06 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.51 | 50,000 | 275,500 | 374,331 |
| Nov 06 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 15.99 | 50,000 | 799,500 | 324,331 |
| Nov 06 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.51 | 50,000 | 275,500 | 190,000 |
| Oct 03 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.51 | 30,000 | 165,300 | 354,331 |
| Oct 03 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 17.87 | 30,000 | 536,100 | 324,331 |
| Oct 03 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.51 | 30,000 | 165,300 | 0 |
| Sep 13 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 0.00 | 10,395 | 0 | 326,908 |
| Sep 13 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 19.26 | 2,577 | 49,633 | 324,331 |
| Apr 03 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 7.18 | 63,109 | 453,123 | 379,622 |
| Apr 03 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 25.00 | 63,109 | 1,577,725 | 316,513 |
| Apr 03 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 7.18 | 63,109 | 453,123 | 0 |
| Mar 27 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 7.18 | 100,000 | 718,000 | 416,513 |
| Mar 27 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 23.14 | 100,000 | 2,314,000 | 316,513 |
| Mar 27 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 7.18 | 100,000 | 718,000 | 63,109 |
| Feb 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.56 | 100,000 | 556,000 | 416,513 |
| Feb 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 21.66 | 100,000 | 2,166,000 | 316,513 |
| Feb 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.56 | 23,000 | 127,880 | 339,513 |
| Feb 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 22.20 | 23,000 | 510,600 | 316,513 |
| Feb 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.56 | 100,000 | 556,000 | 23,000 |
| Feb 15 2019 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.56 | 23,000 | 127,880 | 0 |
| Dec 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.04 | 13,499 | 68,035 | 330,012 |
| Dec 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.04 | 13,499 | 68,035 | 330,012 |
| Dec 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 21.02 | 13,499 | 283,749 | 316,513 |
| Dec 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 21.02 | 13,499 | 283,749 | 316,513 |
| Dec 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.04 | 13,499 | 68,035 | 0 |
| Dec 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.04 | 13,499 | 68,035 | 0 |
| Nov 16 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 17.45 | 9,296 | 162,215 | 318,992 |
| Nov 16 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 17.45 | 2,479 | 43,259 | 316,513 |
| Nov 02 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.04 | 12,000 | 60,480 | 340,288 |
| Nov 02 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 14.16 | 12,000 | 169,920 | 328,288 |
| Nov 02 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.04 | 12,000 | 60,480 | 13,499 |
| Oct 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Buy | 5.04 | 12,000 | 60,480 | 340,288 |
| Oct 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Sell | 17.77 | 12,000 | 213,240 | 328,288 |
| Oct 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 5.04 | 12,000 | 60,480 | 25,499 |
| Sep 12 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Med ... | Option Exercise | 18.80 | 129,314 | 2,431,103 | 129,314 |
| Sep 06 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 5.50 | 22,500 | 123,750 | 350,788 |
| Sep 06 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 18.53 | 22,500 | 416,925 | 328,288 |
| Sep 06 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 5.50 | 22,500 | 123,750 | 0 |
| Aug 20 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 5.51 | 50,000 | 275,500 | 328,288 |
| Aug 20 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 5.51 | 50,000 | 275,500 | 30,000 |
| Aug 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 5.50 | 22,500 | 123,750 | 300,788 |
| Aug 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 20.56 | 22,500 | 462,600 | 278,288 |
| Aug 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 5.50 | 22,500 | 123,750 | 22,500 |
| Jul 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 5.50 | 22,500 | 123,750 | 300,788 |
| Jul 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 21.20 | 22,500 | 477,000 | 278,288 |
| Jul 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 5.50 | 22,500 | 123,750 | 45,000 |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 5.50 | 22,500 | 123,750 | 300,788 |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 20.80 | 22,500 | 468,000 | 278,288 |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 5.50 | 22,500 | 123,750 | 67,500 |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 5.50 | 22,500 | 123,750 | 300,788 |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 22.36 | 7,800 | 174,408 | 292,988 |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 23.47 | 14,700 | 345,009 | 278,288 |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 5.50 | 22,500 | 123,750 | 90,000 |
| Apr 06 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 7.18 | 14,591 | 104,763 | 277,280 |
| Apr 06 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 7.18 | 14,591 | 104,763 | 163,109 |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 4.42 | 7,293 | 32,235 | 262,689 |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 4.42 | 7,293 | 32,235 | 0 |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 24.75 | 2,609 | 64,573 | 255,396 |
| Oct 05 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 0.00 | 75,000 | 0 | 258,005 |
| Oct 05 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 24.41 | 150,000 | 3,661,500 | 150,000 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 9.91 | 33,333 | 330,330 | 216,338 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 23.68 | 33,333 | 789,325 | 183,005 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 9.91 | 33,333 | 330,330 | 216,338 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 23.94 | 33,333 | 797,992 | 183,005 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 9.91 | 33,334 | 330,340 | 216,339 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 23.74 | 33,334 | 791,349 | 183,005 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 9.91 | 33,333 | 330,330 | 66,667 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 9.91 | 33,333 | 330,330 | 33,334 |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 9.91 | 33,334 | 330,340 | 0 |
| May 16 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 5.04 | 12,501 | 63,005 | 183,005 |
| May 16 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 5.04 | 12,501 | 63,005 | 37,499 |
| May 03 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 9.91 | 89,910 | 891,008 | 260,414 |
| May 03 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 23.00 | 88,010 | 2,024,230 | 172,404 |
| May 03 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 23.31 | 1,900 | 44,289 | 170,504 |
| May 03 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 9.91 | 89,910 | 891,008 | 100,000 |
| Apr 18 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 9.91 | 10,090 | 99,992 | 168,143 |
| Apr 18 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 9.91 | 10,090 | 99,992 | 189,910 |
| Mar 17 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 4.42 | 17,707 | 78,265 | 175,760 |
| Mar 17 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 7.18 | 32,300 | 231,914 | 208,060 |
| Mar 17 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 22.53 | 50,007 | 1,126,658 | 158,053 |
| Mar 17 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 4.42 | 17,707 | 78,265 | 7,293 |
| Mar 17 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 7.18 | 32,300 | 231,914 | 177,700 |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 8.99 | 22,000 | 197,780 | 180,053 |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 16.73 | 22,000 | 368,060 | 158,053 |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 8.99 | 22,000 | 197,780 | 0 |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 8.99 | 22,000 | 197,780 | 180,053 |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 15.00 | 22,000 | 330,000 | 158,053 |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 8.99 | 22,000 | 197,780 | 22,000 |
| Sep 26 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 0.00 | 20,000 | 0 | 156,441 |
| Sep 26 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 14.74 | 120,000 | 1,768,800 | 120,000 |
| Sep 02 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 9.73 | 132,662 | 1,290,801 | 267,596 |
| Sep 02 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 10.98 | 131,155 | 1,440,082 | 136,441 |
| Sep 02 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 9.73 | 132,662 | 1,290,801 | 0 |
| Aug 05 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 9.73 | 42,338 | 411,949 | 174,354 |
| Aug 05 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 11.00 | 42,338 | 465,718 | 132,016 |
| Aug 05 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 9.73 | 42,338 | 411,949 | 132,662 |
| Apr 29 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 1.70 | 125,000 | 212,500 | 125,000 |
| Apr 29 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 1.90 | 62,500 | 118,750 | 62,500 |
| Mar 08 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 1.70 | 125,000 | 212,500 | 125,000 |
| Mar 08 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 1.90 | 62,500 | 118,750 | 62,500 |
| Feb 16 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Buy | 0.00 | 65,498 | 0 | 157,248 |
| Feb 16 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Sell | 4.20 | 25,232 | 105,974 | 132,016 |
| Feb 16 2016 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med A ... | Option Exercise | 4.20 | 75,000 | 315,000 | 75,000 |
| Nov 17 2015 | EXEL | EXELIXIS, INC. | Schwab Gisela | EVP and Chief Medical ... | Buy | 0.00 | 3,125 | 0 | 92,924 |
| Nov 17 2015 | EXEL | EXELIXIS, INC. | Schwab Gisela | EVP and Chief Medical ... | Sell | 0.00 | 1,174 | 0 | 91,750 |
| Nov 17 2015 | EXEL | EXELIXIS, INC. | Schwab Gisela | EVP and Chief Medical ... | Option Exercise | 0.00 | 3,125 | 0 | 0 |
| Sep 18 2015 | EXEL | EXELIXIS, INC. | Schwab Gisela | EVP and Chief Medical ... | Option Exercise | 6.21 | 245,000 | 1,521,450 | 245,000 |
| Jul 22 2015 | EXEL | EXELIXIS, INC. | Schwab Gisela | EVP and Chief Medical ... | Option Exercise | 5.51 | 80,000 | 440,800 | 80,000 |
| Jul 22 2015 | EXEL | EXELIXIS, INC. | Schwab Gisela | EVP and Chief Medical ... | Option Exercise | 1.70 | 250,000 | 425,000 | 250,000 |
| Jul 22 2015 | EXEL | EXELIXIS, INC. | Schwab Gisela | EVP and Chief Medical ... | Option Exercise | 1.90 | 125,000 | 237,500 | 125,000 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Sell | 22.50 | 451,812 | 10,165,770 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 9.75 | 118,188 | 1,152,333 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 23.68 | 2,914 | 69,004 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 23.68 | 67,086 | 1,588,596 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 8.87 | 8,301 | 73,630 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 8.87 | 35,699 | 316,650 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 15.32 | 6,559 | 100,484 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 15.32 | 20,441 | 313,156 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 8.98 | 11,842 | 106,341 | 0 |
| Apr 04 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 8.98 | 68,158 | 612,059 | 0 |
| Apr 03 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Buy | 9.75 | 200,000 | 1,950,000 | 251,812 |
| Apr 03 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 9.75 | 200,000 | 1,950,000 | 118,188 |
| Mar 28 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Buy | 9.75 | 51,812 | 505,167 | 74,394 |
| Mar 28 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Sell | 22.37 | 22,582 | 505,159 | 51,812 |
| Mar 28 2006 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 9.75 | 51,812 | 505,167 | 318,188 |
| Jan 21 2005 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 8.98 | 11,842 | 106,341 | 11,842 |
| Jan 21 2005 | ABGX | ABGENIX INC | SCHWAB GISELA MD | Chief Medical Officer | Option Exercise | 8.98 | 68,158 | 612,059 | 68,158 |